Sana Biotechnology
SANA
SANA
125 hedge funds and large institutions have $770M invested in Sana Biotechnology in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $808M → $770M (-$37.8M)
11% less call options, than puts
Call options by funds: $92K | Put options by funds: $103K
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
125
Holding in Top 10
2
Calls
$92K
Puts
$103K
Top Buyers
| 1 | +$6.72M | |
| 2 | +$4.78M | |
| 3 | +$4.72M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.49M |
| 5 |
ABG
Ally Bridge Group
New York
|
+$4.41M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$4.28M | |
| 3 | -$3.25M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$1.57M |
| 5 |
Morgan Stanley
New York
|
-$1.39M |